XML 44 R34.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Segment Information (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2016
Segment Reporting [Abstract] |
Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals | Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
| Quarter Ended December 31, |  | Nine Months Ended December 31,
(In millions) | 2016 |  | 2015 |  | 2016 |  | 2015
Revenues |  |  |  |  |  |  |
Distribution Solutions (1) |  |  |  |  |  |  |
North America pharmaceutical distribution and services | $ | 41,685 |  |  | $ | 39,615 |  |  | $ | 124,271 |  |  | $ | 119,750 |
International pharmaceutical distribution and services | 6,193 |  |  | 6,022 |  |  | 18,794 |  |  | 17,726 |
Medical-Surgical distribution and services | 1,558 |  |  | 1,568 |  |  | 4,657 |  |  | 4,579 |
Total Distribution Solutions | 49,436 |  |  | 47,205 |  |  | 147,722 |  |  | 142,055 |
Technology Solutions - products and services | 694 |  |  | 694 |  |  | 2,098 |  |  | 2,151 |
Total Revenues | $ | 50,130 |  |  | $ | 47,899 |  |  | $ | 149,820 |  |  | $ | 144,206 |
Operating profit |  |  |  |  |  |  |
Distribution Solutions (2) (3) | $ | 813 |  |  | $ | 906 |  |  | $ | 2,592 |  |  | $ | 2,742 |
Technology Solutions (4) (5) | 132 |  |  | 122 |  |  | 126 |  |  | 426 |
Total | 945 |  |  | 1,028 |  |  | 2,718 |  |  | 3,168 |
Corporate Expenses, Net | (91 | ) |  | (95 | ) |  | (270 | ) |  | (320 | )
Interest Expense | (74 | ) |  | (87 | ) |  | (231 | ) |  | (267 | )
Income from Continuing Operations Before Income Taxes | $ | 780 |  |  | $ | 846 |  |  | $ | 2,217 |  |  | $ | 2,581 |
(1) | Revenues derived from services represent less than 2% of this segment’s total revenues.
(2) | Distribution Solutions operating profit for the third quarter and first nine months of 2017 include pre-tax credits of $155 million and $151 million related to our last-in-first-out (“LIFO”) method of accounting for inventories. The third quarter and first nine months of 2016 include pre-tax LIFO charges of $33 million and $215 million. LIFO credits were recognized in 2017 primarily due to the lower full year expectations for price increases.
(3) | Distribution Solutions operating profit for the first nine months of 2016 includes a pre-tax gain of $52 million recognized from the 2016 second quarter sale of our ZEE Medical business, and for the first nine months of 2017 and 2016 includes $142 million and $76 million of net cash proceeds representing our share of net settlements of antitrust class action lawsuits against drug manufacturers.
(4) | Technology Solutions operating profit for the first nine months of 2016 includes a pre-tax gain of $51 million recognized from the 2016 first quarter sale of our nurse triage business.
(5) | Technology Solutions operating profit for the first nine months of 2017 includes a non-cash pre-tax charge of $290 million for goodwill impairment related to the EIS reporting unit and for the third quarter and first nine months of 2017 includes $31 million and $58 million of expenses directly associated with the proposed Healthcare Technology Net Asset Exchange.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration